FOXP1 and diffuse large B-cell lymphoma: It is also notable that MYC-driven DLBCL (where FOXP1 is commonly upregulated as a consequence of MYC suppression of miR-34a) are sensitive to inhibitors of the DNA damage response, which is being explored as a therapeutic strategy (37).